Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huating Li

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 12, 2024
Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks-Brief ReportHongwei Ji, Charumathi Sabanayagam, Kunihiro Matsushita, et al.
Diabetes|July 16, 2014
Negative regulation of DsbA-L gene expression by the transcription factor Sp1Qichen Fang, Wenjing Yang, Huating Li, et al.
Scientific Reports|November 30, 2017
Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related DiseasesLiang Wu, Qingchun Pan, Guangyu Wu, et al.
Journal of Hepatology|August 3, 2010
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglycerideHuating Li, Qichen Fang, Fei Gao, et al.
The Lancet. Diabetes & Endocrinology|March 27, 2026
Can artificial intelligence bridge the gaps for primary diabetes care in low-income and middle-income countries?Zhouyu Guan, Huating Li, Sergio Hernández-Jiménez, et al.
Gut|January 19, 2012
Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in miceDewei Ye, Francois Y L Li, Karen S L Lam, et al.
Microbiome|January 14, 2025
Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver diseaseEmmanouil Nychas, Andrea Marfil-Sánchez, Xiuqiang Chen, et al.
Scientific Reports|January 26, 2016
Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver TransplantationDewei Ye, Huating Li, Yudong Wang, et al.
Scientific Reports|July 22, 2017
Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucoseJing Zhang, Huating Li, Hu Zhou, et al.
IEEE Transactions on Bio-Medical Engineering|February 11, 2022
Mixed-Weight Neural Bagging for Detecting m<sup>6</sup>A Modifications in SARS-CoV-2 RNA SequencingRuhan Liu, Liang Ou, Bin Sheng, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Arteriosclerosis, Thrombosis, and Vascular Biology|December 12, 2024
Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks-Brief ReportHongwei Ji, Charumathi Sabanayagam, Kunihiro Matsushita, et al.
Diabetes|July 16, 2014
Negative regulation of DsbA-L gene expression by the transcription factor Sp1Qichen Fang, Wenjing Yang, Huating Li, et al.
Scientific Reports|November 30, 2017
Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related DiseasesLiang Wu, Qingchun Pan, Guangyu Wu, et al.
Journal of Hepatology|August 3, 2010
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglycerideHuating Li, Qichen Fang, Fei Gao, et al.
The Lancet. Diabetes & Endocrinology|March 27, 2026
Can artificial intelligence bridge the gaps for primary diabetes care in low-income and middle-income countries?Zhouyu Guan, Huating Li, Sergio Hernández-Jiménez, et al.
Gut|January 19, 2012
Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in miceDewei Ye, Francois Y L Li, Karen S L Lam, et al.
Microbiome|January 14, 2025
Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver diseaseEmmanouil Nychas, Andrea Marfil-Sánchez, Xiuqiang Chen, et al.
Scientific Reports|January 26, 2016
Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver TransplantationDewei Ye, Huating Li, Yudong Wang, et al.
Scientific Reports|July 22, 2017
Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucoseJing Zhang, Huating Li, Hu Zhou, et al.
IEEE Transactions on Bio-Medical Engineering|February 11, 2022
Mixed-Weight Neural Bagging for Detecting m<sup>6</sup>A Modifications in SARS-CoV-2 RNA SequencingRuhan Liu, Liang Ou, Bin Sheng, et al.
Pageof 11